DaVita
DVA
#1913
Rank
S$13.08 B
Marketcap
S$207.98
Share price
3.00%
Change (1 day)
37.92%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$17.84

According to DaVita's latest financial reports the company's current EPS (TTM) is S$17.93. In 2025 the company made an earnings per share (EPS) of S$13.07 a decrease over its 2024 EPS that were of S$14.25.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$17.8436.51%
2025S$13.07-8.25%
2024S$14.2544.94%
2023S$9.8327.26%
2022S$7.72-35.56%
2021S$11.9944.1%
2020S$8.3219.7%
2019S$6.95540.48%
2018S$1.08-76.07%
2017S$4.53-19.31%
2016S$5.62242.52%
2015S$1.64-62.87%
2014S$4.4213.43%
2013S$3.898.45%
2012S$3.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.20 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$15.85-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$44.83 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.44-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA